Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Mol Carcinog. 2020 Aug 20;59(10):1227–1240. doi: 10.1002/mc.23251

Figure 4. Comparative phenotypic changes induced in PanC-PDX tumor explants after treating with BMJ or GEM alone or as combination.

Figure 4.

Representative pictographs (x200) of hematoxylin and eosin stained (A) PDX272, (B) PDX266, and (C) PDX271 explant tumors harvested after active dosing with the drug/s (day 32 or day 35) or after drug-washout phase (day 64). Descriptive details of the histopathological changes induced by drug/s is elaborated in the Results section.